Melola Discovery

← Melola Discovery

Journal SINTA 1

Hospital-acquired Skin and Skin-structure Infection in COVID-19 Infected Patient with Prolonged Hospitalization

ACTA MEDICA INDONESIANA · Vol. 53 No. 1 (2021)

ISSN
2338-2732, 0125-9326
Published
2021-03-31
Publisher
The Indonesian Society of Internal Medicine
Language
eng

Abstract

Acute bacterial skin and skin-structure infections (ABSSSI) is defined in 2013 by the US Food and Drug Administration as a bacterial cellulitis/erysipelas, major skin abscesses, and wound infections. The Infectious Diseases Society of America (IDSA) in 2014 classifies skin and soft-tissue infection (SSTI) as either non-purulent (which includes cellulitis, erysipelas, and necrotizing infection) or purulent (including furuncle, carbuncle, and abscess). Among hospitalized patients with SSTI, healthcare-associated infections account for 73.5% of all cases. Notably, skin and skin-structure infections caused by Pseudomonas aeruginosa, a common hospital pathogen, was reported to cause higher total cost and longer hospital length of stay compared to non-P. aeruginosa cases, despite causing only approximately 5.7% of all healthcare-associated SSTIs. Infection with P. aeruginosa should always be considered in non-healing skin infections in patients with prolonged hospitalization and antibiotic exposure. Tissue culture, preferably taken by surgical debridement, should be promptly performed; and when hospital-infection is suspected, appropriate antibiotics should be started along with removal of all devitalized tissue and to promote skin and soft tissue healing. Expedited discharge should be considered when possible, with adequate antibiotic treatment and follow up for definitive wound treatment.

Keywords

Collaboration network of the authors

40 authors · 160 co-authorship links · showing the 40 most connected

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Robert SintoAffiliation unknown6
Khie Chen LieAffiliation unknown4
Erni J NelwanAffiliation unknown4
Leonard NainggolanAffiliation unknown4
Sharifah ShakinahAffiliation unknown4
Cleopas Martin RumendeAffiliation unknown3
Mulya Rahma KaryantiAffiliation unknown2
Erpryta N TetrasiwiAffiliation unknown2
Randy AdiwinataAffiliation unknown2
Ikhwan RinaldiAffiliation unknown2
Suhendro SuwartoAffiliation unknown1
Iqbal Zein AssyidiqieAffiliation unknown1
Hindra Irawan SatariAffiliation unknown1
Sri Rezeki HadinegoroAffiliation unknown1
Tonny LohoAffiliation unknown1
Helio GuterresAffiliation unknown1
Adeline Intan PasaribuAffiliation unknown1
Ralalicia LimatoAffiliation unknown1
Retno S WardaniAffiliation unknown1
Retno WahyuningsihAffiliation unknown1
Adeline PasaribuAffiliation unknown1
Kuntjoro HarimurtiAffiliation unknown1
Nadia A MulansariAffiliation unknown1
Richella K LaudittaAffiliation unknown1
Hamzah ShatriAffiliation unknown1
Ari Fahrial SyamAffiliation unknown1
Murdani AbdullahAffiliation unknown1
Ignatius Bima PrasetyaAffiliation unknown1
Haryanto SuryaAffiliation unknown1
Benedictus StefanusAffiliation unknown1
Irsan HasanAffiliation unknown1
Ris Raihan FelimAffiliation unknown1
Anna RozaliyaniAffiliation unknown1
Dita AditianingsihAffiliation unknown1
Mardiastuti WahidAffiliation unknown1
Siti PratiekauriAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, first harvested 8 Nov 2026, last seen 16 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Hospital-acquired Skin and Skin-structure Infection  in COVID-19 Infected Patient with Prolonged Hospitalization</dc:title>
	<dc:creator>Nelwan, Erni Juwita</dc:creator>
	<dc:creator>Tunjungputri, Rahajeng N</dc:creator>
	<dc:creator>Tunjung, Narottama</dc:creator>
	<dc:creator>Widodo, Djoko</dc:creator>
	<dc:subject xml:lang="en-US">Hospital-acquired skin</dc:subject>
	<dc:subject xml:lang="en-US">skin-structure infection</dc:subject>
	<dc:subject xml:lang="en-US">COVID-19</dc:subject>
	<dc:subject xml:lang="en-US">prolonged hospitalization</dc:subject>
	<dc:description xml:lang="en-US">Acute bacterial skin and skin-structure infections (ABSSSI) is defined in 2013 by the US Food and Drug Administration as a bacterial cellulitis/erysipelas, major skin abscesses, and wound infections. The Infectious Diseases Society of America (IDSA) in 2014 classifies skin and soft-tissue infection (SSTI) as either non-purulent (which includes cellulitis, erysipelas, and necrotizing infection) or purulent (including furuncle, carbuncle, and abscess). Among hospitalized patients with SSTI, healthcare-associated infections account for 73.5% of all cases. Notably, skin and skin-structure infections caused by Pseudomonas aeruginosa, a common hospital pathogen, was reported to cause higher total cost and longer hospital length of stay compared to non-P. aeruginosa cases, despite causing only approximately 5.7% of all healthcare-associated SSTIs. Infection with P. aeruginosa should always be considered in non-healing skin infections in patients with prolonged hospitalization and antibiotic exposure. Tissue culture, preferably taken by surgical debridement, should be promptly performed; and when hospital-infection is suspected, appropriate antibiotics should be started along with removal of all devitalized tissue and to promote skin and soft tissue healing. Expedited discharge should be considered when possible, with adequate antibiotic treatment and follow up for definitive wound treatment.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2021-03-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/1767</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 53 No. 1 (2021): Acta Medica Indonesiana; 105</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/1767/483</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2021 Acta Medica Indonesiana</dc:rights>
</oai_dc:dc>